Needs Assessment & Target Audience

WEDNESDAY, May 25
6:30 am – 6:30 pm	Registration
12:30 pm – 6:30 pm	CME Station Hours
8:00 am – 12:00 pm	Pre Congress Session I
	W11: Diabetes Technology 2016 Chair: George Grunberger, MD Update on Insulin Pump Therapy and Continuous Glucose Monitoring Bruce W. Bode, MD Initiating and Interpreting Meter/Pump/Sensor Downloads in Your Practice: Case Studies Irl B. Hirsch, MD Automated Predictive Low Glucose Management in Practice: Early Clinical Experience Martin Prazny, MD Role of Diabetes Technologies in Advancing Diabetes Care Satish K. Garg, MD Advances Towards the Bionic Pancreas Ron Brazg, MD Room: Suwannee 16/17 CME Code: 5223
	W21: Inpatient Endocrinology Part 1: Diabetes and Nutrition Chair: Etie S. Moghissi, MD; S. Sethu Reddy, MD Glycemic Management: From Bedside to the Cloud S. Sethu Reddy, MD Approaches to Glycemic Management in the Hospital: ICU and Beyond Guillermo Umpierrez, MD ICU to Floor to Home: Modern Approaches to Transition of Care Etie S. Moghissi, MD Improved Inpatient Glucose Management: Demonstrating the Value to Both Patients and Hospitals Osama Hamdy, MD Room: Suwannee 11/12 CME Code: 7518
	W31: Cardiovascular Medicine for the Endocrinologist Chair: Chris K. Guerin, MD Endocrinologists as Hypertension Specialists Naomi D.L. Fisher, MD Updates in Lipid Management Sergio Fazio, MD Incorporating Metabolism Into the Endocrinologist’s Practice Yehuda Handelsman,MD Dietary Strategies for Improving Cardiovascular Health Jeffrey I. Mechanick, MD Room: Suwannee 18/19 CME Code: 7631
	W41: Comprehensive Approach to Clinical Thyroidology Chair: Mark Lupo, MD Recognizing Ultrasound Patterns in the Assessment of Thyroid Nodules Mark A. Lupo, MD Working with Your Cytopathologist to Improve Diagnostic Accuracy Zubair Baloch, MD Incorporating Nuclear Medicine Into an Endocrine Office J. Anthony Parker, MD Overcoming the Socioeconomic Challenges in a Thyroidology Practice Ryan Hungerford, MD Room: Suwanee 20/21 CME Code: 6256
1:00 pm – 5:00 pm	W12: Inpatient Endocrinology Part 2: What an Endocrinologist Needs to Know About Surgery and What a Surgeon Needs to Know About Endocrinology Chair: Mira Milas, MD;& Jeffrey Garber, MD Thyroid and Parathyroid Session Thyroid and Parathyroid Surgery Antonia Stephen, MD Thyroid and Parathyroid Perioperative Endocrinology Sathya G. Jyothinagaram, MD Case-based Panel Discussion Pituitary and Adrenal Session Pituitary and Adrenal Perioperative Endocrinology Maria Fleseriu, MD Pituitary Surgery Edward R. Laws, MD Adrenal Surgery Daniel Ruan, MD Case-based Panel Discussion
	W22: The Practice of Obesity Medicine in 2016 Chair: J. Michael Gonzalez-Campoy, MD, PhD Guidelines for the Management of Obesity as an Endocrine Disease W. Timothy Garvey, MD Designing a Successful Obesity Medicine Practice Elena A. Christofides, MD From Behavior Modification through Pharmacotherapy to Surgery – An Emphasis on the Team Approach Scott Isaacs, MD Emerging Concepts of Weight and Energy Regulation J. Michael Gonzalez-Campoy, MD, PhD
	W32: Bone Disease in 2016: Beyond the Basics Co-Chairs: Daniel L. Hurley, MD; Rachel Pessah-Pollack, MD Assessing Fracture Risk - The Challenges of DXA and Other Techniques Angelo Licata, MD Hypoparathyroidism: Evolving Therapeutic Options Bart L. Clarke, MD Monitoring Postmenopausal Osteoporosis – Which Modalities and How Often? Michael R. McClung, MD Beyond Oral Bisphosphonates for Postmenopausal Osteoporosis – Sequential Drug Therapy; What's Next on the Horizon Daniel L. Hurley, MD; Rachel Pessah-Pollack, MD
	W42: AACE – ABIM Maintenance of Certification and Mini - Board Review Course Chair: Pauline M. Camacho, MD Speakers: Pauline Camacho, MD; Elise Brett, M; Hossein Gharib, MD; Dace Trence, MD Endocrinology Update 2015 Endocrinology Update 2016
5:30 pm – 7:45 pm	WSS1: Hypoparathyroidism: New Treatment Concepts & Guidelines
5:30 pm – 7:45 pm	WSS2: Concentrated Insulins: Clinical Applications and Use in Practice Settings

THURSDAY, MAY 26
5:15 am – 7:30 am	TSS1: LDL-C Reduction in the Patient with Diabetes: How Low Should We Go and How Should We Get There? Room: Panzacola H 1/2 CME Code: 1575
6:30 am – 6:30 pm	Registration
7:00 am – 6:00 pm	CME Station Hours
9:45 am -2:15 pm	Exhibit Hall Hours
8:00 am – 8:30 am	General Session Announcements
8:30 am – 9:15 am	TGS1: Diabetes and the Microbiome Moderator: George Grunberger, MD Speaker: Robert E. Ratner, MD Room: Panzacola F/G CME Code: 5331
9:15 am – 10:00 am	TGS2: Metabolomics for the Clinician: Implications for the Treatment of Metabolic Disease Moderator: Derek LeRoith, MD Speaker: Christopher B. Newgard, PhD Room: Panzacola F/G CME Code: 8024
10:00 am – 11:00 am	Young Investigator Poster Session in Exhibit Hall
10:15 am – 11:00 am	Product Theaters in the Exhibit Hall
11:15 am – 12:00 pm	TGS3: Co-Evolution of Scientific Disciplines and Therapies for Disorders of Lipid Metabolism Moderator: Jonathan D. Leffert, MD Speaker: Jay D. Horton, MD Room: Panzacola F/G CME Code: 2893
12:00 pm – 1:00 pm	Boxed Lunch in Exhibit Hall
12:00 pm – 12:45 pm	Young Investigator ePoster Oral Presentations
12:30 pm – 2:15 pm	Women of Endocrinology Luncheon Lessons in Leadership: My Path to Presidency (Non-CME) Moderator: Etie S. Moghissi, MD Speaker: Pauline M. Camacho, MD
1:00 pm – 1:45 pm	Product Theater in the Exhibit Hall
1:15pm – 2:00 pm	Product Theaters in the Exhibit Hall
2:15 pm – 3:15 pm	MEET-THE-EXPERTS SESSION I
	T11: The D-Lightful Vitamin D for Health: Truths and Myths Moderator: Timothy S. Bailey, MD Speaker: Michael D. Holick, MD Room: Suwannee 16/17 CME Code: 8253
	T21: How to Initiate Treatment for Type 2 Diabetes Mellitus: One agent at a Time Versus Combination Therapy Moderator: Daniel Einhorn, MD Speakers: Richard E. Pratley, MD vs. Alan J. Garber, MD Room: Suwannee 11/12 CME Code: 7548
	T31: Mild Hypercortisolism Due to Adrenal Adenoma – Is It Really “Subclinical?” Moderator: Janet B. McGill, MD Speaker: Alice C. Levine, MD Room: Suwannee 13/14 CME Code: 4915
	T41: How Low Should You Go: Lipid Management in the PCSK9 Era Moderator: Richard A. Haas, MD Speaker: Robert H. Eckel, MD Room: St. John's 24/25 CME Code: 1886
	T51: Endocrine Hypertension in 2016: Making the Diagnosis Moderator: William D. Zigrang, MD Speaker: William F. Young Jr., MD Room: St. John's 28/29 CME Code: 1354
	T61: Pediatric Endocrinology: Optimizing Growth Moderator: Jay Cohen, MD Speaker: Robert Rapaport, MD Handout:1 Handout:2 Room: Suwannee 20/21 CME Code: 3145
	T71: Practical Strategies for Management of the Pseudo-Endocrine Patient Moderator: Farhad Zangeneh, MD Speaker: Michael McDermott, MD Room: Suwannee 18/19 CME Code: 7336
3:15 pm – 3:30 pm	Coffee Break
3:30 pm – 4:30 pm	MEET-THE-EXPERTS SESSION II
	T12: Options for Treatment of Hypogonadism in Men Desiring Fertility Preservation Handout Moderator: M. Kathleen Figaro, MD Speaker: Natan Bar-Chama, MD Room: Suwannee 15 CME Code: 9554
	T22: Point/Counterpoint: Radioactive Iodine in Papillary Thyroid Cancer: To Use or Not to Use…That Is the Question Moderator: Jonathan Insel, MD Speakers: Kenneth Ain, MD vs. Ian Hay, MD Room: Suwannee 16/17 CME Code: 1959
	T32: Is Insulin Therapy Inevitable in the Management of Diabetes? Moderator: Vivian Fonseca, MD Speaker: Robert E. Ratner, MD Room: Suwannee 20/21 CME Code: 7264
	T42: Mild Hypercortisolism Due to Adrenal Adenoma – Is It Really “Subclinical?” Moderator: Janet B. McGill, MD Speaker: Alice C. Levine, MD Room: Suwannee 13/14 CME Code: 5304
	T52: How Low Should You Go: Lipid Management in the PCSK9 Era Moderator: Richard A. Haas, MD Speaker: Robert H. Eckel, MD Room: St. John's 24/25 CME Code: 9533
	T62: Endocrine Hypertension in 2016: Making the Diagnosis Moderator: Farhad Zanganeh, MD Speaker: William F. Young Jr., MD Room: St. John's 28/29 CME Code: 2042
	T72: Practical Strategies for Management of the Pseudo-Endocrine Patient Moderator: William D. Zigrang, MD Speaker: Michael McDermott, MD Room: Suwannee 18/19 CME Code: 4068
4:30 pm – 4:45 pm	Break
4:45 pm – 5:45 pm	MEET-THE-EXPERTS SESSION III
	T13: The D-Lightful Vitamin D for Health: Truths and Myths Moderator: Timothy S. Bailey, MD Speaker: Michael F. Holick, MD Room: St. John's 24/25 CME Code: 3847
	T23: How to Initiate Treatment for Type 2 Diabetes Mellitus: One agent at a Time versus Combination Therapy Moderator: Daniel Einhorn, MD Speakers: Richard E. Pratley, MD vs. Alan J. Garber, MD Room: Suwannee 11/12 CME Code: 8878
	T33: Pediatric Endocrinology: Optimizing Growth Moderator: Jay Cohen, MD Speaker: Robert Rapaport, MD Room: Suwannee 18/19 CME Code: 8156
	T43: Options for Treatment of Hypogonadism in Men Desiring Fertility Preservation Handout Moderator:M. Kathleen Figaro, MD Speaker: Natan Bar-Chama, MD Room: Suwannee 15 CME Code: 4926
	T53: Point/Counterpoint: Radioactive Iodine in Papillary Thyroid Cancer: To Use or Not to Use…That is the Question Moderator: Jonathan Insel, MD Speakers: Kenneth Ain, MD vs. Ian Hay, MD Room: Suwannee 16/17 CME Code: 9985
	T63: Is Insulin Therapy Inevitable in Management of Diabetes? Moderator: George Grunberger, MD Speaker: Robert E. Ratner, MD Room: Suwannee 20/21 CME Code: 7406
	T73: History of Diabetes Mellitus: 1500 B.C. to Present Moderator: Chris K. Guerin, MD Speaker: Philip Levy, MD Room: Suwannee 13/14 CME Code: 1465
6:00 pm – 7:00 pm	Domestic & International Chapter Receptions
7:15 pm – 9:30 pm	TSS3: Balancing the Evidence: Considering the Clinical Impact of Newer Antihyperglycemic Agents for the Treatment of Type 2 Diabetes Room: Panzacola H 3/4 CME Code: 1284
	TSS4: Patient Centered Care of the Patient with Obesity Room: Panzacola H 1/2 CME Code: 1304

FRIDAY, MAY 27
5:15am – 7:30 am	FSS1: Keeping Pace with CGM Technology: The Path to Successful Implementation Room: Panzacola H 1/2 CME Code: 3374
7:30am – 6:30 pm	Registration
7:30am – 6:30 pm	CME Station Hours
9:45am – 2:15 pm	Exhibit Hall Hours
8:00am – 8:20 am	General Session Announcements
8:20am – 9:05 am	FGS1:Pheochromocytoma: Then and Now - A 90-Year Journey Moderator: Daniel L.Hurley, MD Speaker: William F.Young Jr., MD Room: Panzacola F/G CME Code: 7835
9:15am – 12:00 pm	IN-DEPTH SYMPOSIA SESSION I MOC Points will beavailable for select In-Depth Symposia
	F11: Thryoid Cancer Update Chair: Hossein Gharib, MD Supported by the Hossein Gharib, MD Educational Fund Highlights of the ATA Guidelinesfor Low Risk Differentiated Thyroid Cancer - Histologic and Molecular Approach to Staging Erik K. Alexander, MD Ultrasound Follow-up in PapillaryThyroid Cancer and Use of Alcohol Ablation Therapy for Recurrence Tara Henrichsen, MD Thyroid Cancer Surgery in 2016 Julie Ann Sosa , MD Radioactive Iodine Treatment inThyroid Cancer Gregory A. Wiseman, MD Room: Panzacola H 3/4 CME Code: 1412
	F21: Endocrine Disorders during Pregnancy Chair: Felice A.Caldarella, MD Challenging Cases of Thyroid Disease During Pregnancy James Hennessey, MD Challenging Cases of Diabetes Lois Jovanovic, MD Challenging Cases of Adrenal Disorders Deborah P. Merke, MD Room: Suwannee 13/14 CME Code: 8929
	F31: AACE Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity Chair: W. Timothy Garvey, MD Anthropometric and ClinicalComponents to the Diagnosis: Measurement of Adiposity and Impact on Patient Health Karl Nadolsky, DO Benefits of Weight Loss Treatment Ania Jastreboff, MD The Prescription for Individualized Lifestyle Therapy: Eating Patterns, Evidence and Efficacy Daniel L. Hurley, MD A Patient-Centered Approach for the Individualization of Pharmacotherapy Jeffrey I. Mechanick, MD Putting it Together: An Evidence-Based Algorithm for Obesity Management W. Timothy Garvey, MD Room: St. John's 24/25 CME Code: 7583
	F41: Diabetes Update 2016 Chair: Robert R. Henry, MD Role of PCSK9 Inhibitors inDiabetes: Indications for Use and Avoiding Misuse PamR. Taub, MD CV Outcomes Trials in Diabetes:Selected Lessons Learned Thus Far Darren McGuire, MD EMPA-REG RESULTS: Implications forCVD Prevention in Type 2 Diabetes Robert Eckel, MD Potential Mechanisms for CV OutcomeBenefits with Empagliflozin Steven E. Nissen, MD SGLT2 Inhibitors and DKADevelopment: Epidemiology, Pathogenesis and Prevention of DKA in Diabetes Lance Sloan, MD Room: Suwannee 11/12 CME Code: 2398
	F51: Practical Clinical Guide to Endocrine Diseases for Nurse Practitioners/ Physician Assistants Chairs: W. Reid Litchfield, MD; Sondra O’ Callaghan, PA Diabetes Mellitus, Obesity and Hyperlipidemia Israel Hartman, MD Clinical Pearls for the Evaluation and Treatment of Thyroid Disorders W. Reid Litchfield, MD Screening for Common Adrenal, Pituitary, and Reproductive Diseases Richard Auchus, MD Calcium/Bone Disorders Steve Petak, MD Room: Suwannee 20/21 CME Code: 8505
	F61: Novel Developments in Diabetes Technology (Non-CME) Moderators: Timothy Bailey, MD; Alan Garber, MD; R. Mack Harrell, MD Progress Toward Closed Loop Systems Scott W. Lee, MD Progress Toward the Bionic Pancreas Edward Damiano, PhD Room: Suwannee 18/19
12:00pm – 2:15 pm	Exhibit Hall Break
12:00pm – 1:00 pm	Boxed Lunch in Exhibit Hall
12:00pm – 12:45 pm	ePoster Oral Presentations
12:30pm – 2:15 pm	FIT Luncheon
1:00pm – 1:45 pm	Product Theater in the Exhibit Hall
1:15pm– 2:00 pm	Product Theaters in the Exhibit Hall
2:15pm – 5:00 pm	IN-DEPTH SYMPOSIASESSION II MOC Points will beavailable for select In-Depth Symposia
	F12: A Tributeto Saul Hertz: 75th Anniversary of the Use of Radioactive Iodine Chair: Jeffrey R.Garber, MD; Lewis E. Braverman, MD 131 Iodine Therapy: A Brief History Lewis E. Braverman, MD The Sodium/Iodide Symporter (NIS): From Patient to Molecule and Back Nancy Carrasco, MD Diagnostic and Therapeutic Uses of Radioactive Iodine Douglas Van Nostrand, MD Targeted Approaches for Enhancing RAI Avidity in Thyroid Cancer Alan Ho, MD Room: Suwannee 15 CME Code: 9758
	F22: TransgenderMedicine: What an Endocrinologist Should Know Chair: Vin Tangpricha, MD How to Treat Adolescents with Transgender Identity Stephen M. Rosenthal, MD Standards of Care in the Diagnosisof Gender Dysphoria Eli Coleman, PhD Guidelines for the Clinical Care ofPersons with Gender Dysphoria Wylie Hembree, MD Sex Reassignment Surgery Stan Monstrey, MD Room: Suwannee 11/12 CME Code: 9137
	F32: Endocrinology and Aging, or, “The Taper” Chair: Peter A. Singer, MD Muscle Loss and Aging - Even Arnoldhas Sarcopenia John Morley, MBBCh Does Growth Hormone Keep You Younger? Shlomo Melmed, MD Men Getting Older - Will Testosterone Keep Him Younger? Alvin Matsumoto, MD Women Getting Older - and Even Better Holly L. Thacker, MD Thyroid Disorders in “Oldsters”: Its Ups and Downs Stephanie Lee, MD Room: Panzacola H 3/4 CME Code: 2266
	F42: Neuroendocrine Tumor (NET) Syndromes Chair: Aaron I. Vinik, MD Update on Pheochromocytoma and Paraganglioma: Implications for Clinical Practice Karel Pacak, MD Peptide Receptor Radio-NuclideTherapy as a Novel, Rationale Option of Care for Metastatic NETs Tom O’Dorisio, MD Results of New Clinical Trials and Implications for Therapy of NETS Matt Kulke, MD Update on Surgical Management of NETS James Howe, MD Room: Suwannee 16/17 CME Code: 1040
	F52: 8th AACE/SMNE Joint Session: Reflections and Future Directions in Endocrinology (presented in Spanish) Co-Chairs: Myriam Allende-Vigo, MD & Miguel A.Madero, MD The Mexican Acromegaly Registry: An In-Depth Analysis of the Epidemiology of the Disease Moises Mercado, MD Role of Magnesium in the Impaired Glucose Metabolism Jesus Guerrero Romero, MD The Last 25 Years has Changed Diabetes from A to Z Jaime Davidson, MD Update in Thyroid Cancer Maria Cabanillas, MD Room: Suwannee 18/19 CME Code: 9910
	F62: The Future of Endocrinology Reimbursement Co-Chairs: Katherine Roberts, MD; Howard Lando, MD Opting out of Medicare Katherine Roberts, MD Merit-Based Incentive Payment System (MIPS) and Medicare Access & CHIP Reauthorization Act of 2015 (MACRA): Making Sense of the New Regulations Jill Rathbun, MD Creating a New Business Model For Endocrinology: The ACO and the Endocrinologist William Biggs, MD Informatics 2016: How Do We Get from Meaningful Use to Precision Medicine? Douglas Fridsma, MD Room: Suwannee 20/21 CME Code: 1073
5:00pm – 6:15 pm	Poster Session in Exhibit Hall
5:00pm – 6:30 pm	Wine & Cheese Reception in Exhibit Hall
6:15pm – 7:00 pm	Product Theaters in the Exhibit Hall
7:00pm – 9:15 pm	FSS3: Basal Insulin 4.0: Updating Your Clinical Practice with Ultralong-acting Insulins Room: Panzacola H 1/2 CME Code: 6224
7:00pm – 9:15 pm	FSS4: Updates in Cardiovascular Risk Reduction in Type 2 Diabetes: New Insights and Outcomes in Treatment Options Room: Panzacola H 3/4 CME Code: 1809

SATURDAY, MAY 28
7:30am – 5:00 pm	Registration
7:00am – 6:00 pm	CME Station Hours
9:45am -2:15 pm	Exhibit Hall Hours
8:00am – 8:15 am	Award Presentations
8:15am – 9:00 am	SGS1: The Role of Molecular Markers in Thyroid Nodule Management: Then and Now Moderator: Hossein Gharib, MD Speaker:Yuri Nikiforov, MD Room: Panzacola F/G CME Code: 3245
9:00am – 9:15 am	Award Presentations
9:15am – 10:00 am	SGS2: The Obesity Epidemic, A Public Health Emergency? Moderator:Yank Coble, MD Speaker: Regina Benjamin, MD Room: Panzacola F/G CME Code: 3103
	SGS3: Select Abstract Oral Presentations I Moderator: S. Sethu Reddy, MD THE PREVALENCE OF FASTING-EVOKED EN-ROUTE HYPOGLYCEMIA IN DIABETES (FEEHD) IN CLINICAL PRACTICE: A PILOTSURVEY Saleh Aldasouqi, MD CONTEMPLATING AN ADDITIONAL ORAL AGENTFOR YOUR PATIENT WITH TYPE 2 DIABETES? CONSIDER POSSIBLE INTERACTION BETWEENQUALITY OF YOUR CONVERSATION WITH PATIENT’S ATTEMPTS AT BARGAINING ANDSELF-REPORTED OUTCOMES - LESSONS FROM THE INTRODIA™ STUDY Leo Seman, MD A RANDOMIZED CONTROL TRIAL ON REDUCTIONOF HEMOGLOBIN A1C USING CELL PHONES, COMMUNITY HEALTH WORKERS OR COMBINATIONOF BOTH IN A DISTRICT OF COLUMBIA AFRICAN AMERICAN POPULATION Nesreen Hagahmed, MBBS Room: Panzacola H 1/2 CME Code: 6849
	SGS4: Select Abstract Oral Presentations II Moderator: David Lieb, MD SYSTEMATIC REVIEW OF THE POSITIVE PREDICTIVE VALUE OF RAS MUTATIONSIN CYTOLOGICALLY INDETERMINATE THYROID NODULES Mark Lupo, MD RADIO FREQUENCY ABLATION: AN INNOVATIVE TREATMENT FORADRENAL NEOPLASMS Lima Lawrence, MD USE OF A DIGITAL HEALTH OFFERING TO OPTIMIZE STATIN TREATMENT IN PATIENTS WITH TYPE 2 DIABETES Juan Frias, MD, FACE Room: Panzacola H 3/4 CME Code: 8071
10:00am – 11:00 am	Late Breaking Poster Session in Exhibit Hall
10:15am – 11:00 am	Product Theaters in the Exhibit Hall
11:00am – 11:15 am	Award Presentations
11:15am – 12:00 pm	SGS5: Osteoporosis Drugs: Then and Now Moderator: Pauline M. Camacho, MD Speaker: Michael R. McClung, MD Room: Panzacola F/G CME Code: 4744
11:15am – 12:15 pm	SGS6: Late Breaking Oral Presentations (Non-CME) Moderators: S. Sethu Reddy, MD; David C. Lieb, MD Room: Panzacola H 1/2
12:15pm – 2:00 pm	AACE Annual Business Meeting Luncheon
2:15pm – 3:15 pm	MEET-THE-EXPERTS SESSION I
	S11: Treatment of Severe Pediatric Obesity Moderator: Sripriya Raman, MD Speaker: Ilene Fennoy, MD Room: Suwannee 20/21 CME Code: 1741
	S21: Update on the Evaluation and Treatment of Paget’s Disease Moderator: Ved V.Gossain, MD Speaker: Henry G. Bone III, MD Room: St. John's 28/29 CME Code: 1429
	S31: Hormonal Treatment of Menopausal Women: What Are the Data Telling Us (and Not Telling Us?) Moderator: Kathleen Wyne, MD Speaker: S. Mitchell Harman, MD Room: Suwannee 16/17 CME Code: 3734
	S41: Diagnosis and Management of Anabolic Steroid Abuse Slides PDF Moderator: Sri Prakash Mokshagundam, MD Speaker: Darius A. Paduch, MD Room: Suwannee 15 CME Code: 8320
	S51: Improving the Long-Term Management of Benign Thyroid Nodules Moderator: Sandra L.Weber, MD Speaker: Stephanie Lee, MD Room: St John's 24/25 CME Code: 6429
	S61: Active Surveillance Versus Surgery in Low-Risk Thyroid Cancer Moderator: Gary A.Trager,MD Speaker: Juan P. Brito,MD Room: Suwannee 13/14 CME Code: 1901
	S71: Hyponatremia: Clinical Conundrums in Diagnosis and Treatment Moderator: David S.H.Bell, MD Speaker: Joseph G.Verbalis, MD Room: Suwannee 11/12 CME Code: 2819
	S81: Approach to the Transgender Adolescent: The Evaluation Moderator: Vin Tangpricha, MD Speaker: Stephen M. Rosenthal, MD Room: Suwannee 18/19 CME Code: 3838
3:15pm– 3:30pm	Coffee Break
3:30pm – 4:30 pm	MEET-THE-EXPERTS SESSION II
	S12: Challenging Pituitary Cases Moderator: Anne L. Leddy, MD Speaker: Eliza B. Geer,MD Room: Suwannee 16/17 CME Code: 4222
	S22: Emerging Therapies for Treatment of Hypoparathyroidism Moderator: Dace Trence,MD Speaker: Bart L.Clarke, MD Room: Suwanee 20/21 CME Code: 4887
	S32: Approach to the Transgender Adolescent: A Case Study of the Jennings Family Moderator: Stephen M. Rosenthal, MD; Vin Tangpricha,MD Case Study: The Jennings Family (“I am Jazz”) Room: Suwannee 18/19 CME Code: 4907
	S42: Active Surveillance Versus Surgery in Low-Risk Thyroid Cancer Moderator: Gary A.Trager, MD Speaker: Juan P. Brito,MD Room: Suwannee 13/14 CME Code: 9250
	S52: Diagnosis and Management of Anabolic Steroid Abuse Slides PDF Moderator: Sri Prakash Mokshagundam,MD Speaker: Darius Paduch, MD Room: Suwannee 15 CME Code: 7699
	S62: Improving the Long-Term Management of Benign Thyroid Nodules Moderator: Elise Brett, MD Speaker: Stephanie Lee, MD Room: St. John's 24/25 CME Code: 3718
	S72: Osteoporosis Drug Holidays: Why, When and What's After Moderator: Victor L. Roberts, MD Speaker: Paul D. Miller, MD Room: St. John's 28/29 CME Code: 4714
	S82: Hyponatremia: Clinical Conundrums in Diagnosis and Treatment Moderator: David S. H. Bell, MD Speaker: Joseph G. Verbalis, MD Room: Suwannee 11/12 CME Code: 5867
4:30pm – 4:45 pm	Break
4:45pm – 5:45 pm	MEET-THE-EXPERTS SESSION III
	S13: Treatmentof Severe Pediatric Obesity Moderator: Sripriya Raman, MD Speaker: Ilene Fennoy,MD Room: Suwannee 15 CME Code: 9405
	S23: Hormonal Treatment of Menopausal Women: What Are the Data Telling Us (and Not Telling Us?) Moderator: Rhoda H.Cobin, MD Speaker: S. Mitchell Harman, MD Room: St. John's 24/25 CME Code: 9365
	S33: Update on the Evaluation and Treatment of Paget’s Disease Moderator: Gary W. Edelson, MD Speaker: Henry G. Bone III, MD Room: Suwannee 11/12 CME Code: 1235
	S43: Challenging Pituitary Cases Moderator: Alex Tessnow, MD Speaker: Eliza Geer, MD Room: Suwannee 16/17 CME Code: 7716
	S53: Osteoporosis - Drug Holidays: Why, When and What's After Moderator: Paul V.Tomasic, MD Speaker: Paul D. Miller, MD Room: St. John's 28/29 CME Code: 6711
	S63: Emerging Therapies for Treatment of Hypoparathyroidism Moderator: Donald A. Bergman, MD Speaker: Bart L. Clarke, MD Room: Suwannee 20/21 CME Code: 9542
	S73: Medicine After the Holocaust Moderator: Richard S. Rosenthal, MD Speaker: Sheldon Rubenfeld, MD Room: Suwannee 13/14 CME Code: 9817
	S83: Approach to the Transgender Adolescent: A Case Study of the Jennings Family Moderator: Stephen M. Rosenthal, MD Case Study: The Jennings Family (“I am Jazz”) Room: Suwannee 18/19 CME Code: 9648
6:30pm	ACE Convocation
7:30pm	President’s Gala

SUNDAY, MAY 29
7:00 am – 11:00 am	Registration
7:00 am - 8:00 am	Attendee Breakfast Room: Panzacola F/G
7:30 am – 12:00 pm	CME Station Hours
8:00 am – 8:15 am	General Session Announcements
8:15 am – 8:45 am	SGS8: Controversies in the Approach to Adrenal Nodules Moderator: Antonia E. Stephen, MD Panel: Karel Pacak, MD, Antonia E. Stephen, MD; Peter M. Sadow, MD Room: Panzacola F/G CME Code: 7017
8:45 am – 9:30 am	SGS9: The Mystery of the Hidden Parathyroid Adenoma Moderator: Jennifer L. Marti, MD Panel: Azeez Farooki, MD; Peter M. Sadow, MD Room: Panzacola F/G CME Code: 5418
9:30 am – 9:45 am	Coffee Break
9:45 am – 11:00 am	SGS7: Dilemmas in Thyroid Cancer: Endocrine/Surgical Consensus Moderator: Gregory W. Randolph, MD Speaker: Peter A. Singer, MD, Gregory W. Randolph, MD; Peter M. Sadow, MD Room: Panzacola F/G CME Code: 1043
11:00 am – 11:15 am	Final Announcements; Adjournment

Needs Assessment

The Program Committee of the American Association of Clinical Endocrinologists (AACE), composed of physician experts, consistently strives to monitor issues and trends in the diverse areas of endocrinology. Its mission is to continually help AACE members enhance and update their knowledge so that they can provide the highest-quality care to patients.

The physician experts presenting at the Annual Scientific and Clinical Congress deliver programs designed to highlight the importance of the endocrinologist’s role in the intervention and treatment of endocrine-related diseases. Scientific, technological, economic, social, and political factors are presented so that endocrinologists are informed about the latest scientific advances and treatment modalities.

The topics and educational objectives for the 2016 program were developed from a wide variety of sources, including the Program Committee, expert and clinical advisor opinions, and literature reviews about current challenges in healthcare. Educational needs were also identified by attendees at the 2015 AACE Annual Scientific and Clinical Congress, utilizing outcome measurements focused on increasing participants’ knowledge and skills in key topics related to endocrinology. These included both quantitative and qualitative evaluations used for each accredited CME activity.

Based on these findings, the following topics were identified as being future educational needs of the AACE membership:

Adrenal
Bone
Diabetes
General Endocrinology
Lipids
Neuroendocrine Tumors
Obesity
Reproductive/ Growth Hormone/Testosterone
Thyroid

Target Audience

All physicians and allied health professionals interested in the study, diagnosis, and treatment of endocrine-related diseases.